I obtained my PhD degree in Turin, Italy, researching on novel therapeutic strategies for a rare childhood cancer named Rhabdomyosarcoma. I then moved to the fascinating world of stem cell research, joining the laboratory of Dr. Vivian Li at The Francis Crick Institute in London, UK. There, I studied the role that WNT-regulated transcriptional repressors have in determining stem cell fate using intestinal organoids and transgenic mice as model systems. In February 2022, I joined the lab of Dr. Emiliano Cocco as a Postdoctoral Associate where I am currently studying signaling pathway addiction and mechanisms of resistance to targeted therapy in tumors harboring rare oncogenic drivers.
I obtained my PhD degree in Turin, Italy, researching on novel therapeutic strategies for a rare childhood cancer named Rhabdomyosarcoma. I then moved to the fascinating world of stem cell research, joining the laboratory of Dr. Vivian Li at The Francis Crick Institute in London, UK. There, I studied the role that WNT-regulated transcriptional repressors have in determining stem cell fate using intestinal organoids and transgenic mice as model systems. In February 2022, I joined the lab of Dr. Emiliano Cocco as a Postdoctoral Associate where I am currently studying signaling pathway addiction and mechanisms of resistance to targeted therapy in tumors harboring rare oncogenic drivers.